Crestwood Advisors Group LLC Has $381,000 Stock Position in Waters Co. (NYSE:WAT)

Crestwood Advisors Group LLC increased its stake in Waters Co. (NYSE:WAT) by 6.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,026 shares of the medical instruments supplier’s stock after acquiring an additional 61 shares during the quarter. Crestwood Advisors Group LLC’s holdings in Waters were worth $381,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Kennebec Savings Bank acquired a new position in shares of Waters in the third quarter worth approximately $33,000. Bank of Jackson Hole Trust acquired a new position in shares of Waters in the fourth quarter worth approximately $34,000. Ashton Thomas Securities LLC acquired a new position in shares of Waters in the third quarter worth approximately $35,000. Fortitude Family Office LLC lifted its stake in shares of Waters by 235.7% in the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after acquiring an additional 66 shares during the period. Finally, R Squared Ltd acquired a new position in shares of Waters in the fourth quarter worth approximately $63,000. 94.01% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms recently commented on WAT. Bank of America cut their price objective on Waters from $430.00 to $410.00 and set a “neutral” rating on the stock in a research note on Thursday, February 13th. Sanford C. Bernstein raised Waters from a “market perform” rating to an “outperform” rating and set a $430.00 price target on the stock in a research note on Friday, January 10th. Stifel Nicolaus boosted their price target on Waters from $332.00 to $360.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Scotiabank raised Waters from a “sector perform” rating to a “sector outperform” rating and boosted their price target for the company from $430.00 to $450.00 in a research note on Thursday, February 13th. Finally, JPMorgan Chase & Co. boosted their price target on Waters from $340.00 to $380.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. Eleven investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Waters presently has a consensus rating of “Hold” and a consensus price target of $390.40.

Waters Price Performance

Shares of NYSE:WAT opened at $381.31 on Wednesday. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14. Waters Co. has a twelve month low of $279.24 and a twelve month high of $423.56. The stock’s 50 day moving average is $389.11 and its 200-day moving average is $366.82. The firm has a market capitalization of $22.64 billion, a price-to-earnings ratio of 35.60, a PEG ratio of 3.79 and a beta of 1.01.

Waters (NYSE:WAT) last announced its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. Sell-side analysts forecast that Waters Co. will post 12.86 EPS for the current fiscal year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.